maysiglu 100 mg filmsko obložene tablete
sitagliptin - filmsko obložena tableta - sitagliptin 100 mg / 1 tableta - sitagliptin
maysiglu 50 mg filmsko obložene tablete
sitagliptin - filmsko obložena tableta - sitagliptin 50 mg / 1 tableta - sitagliptin
maysiglu 50 mg filmsko obložene tablete
sitagliptin - filmsko obložena tableta - sitagliptin 50 mg / 1 tableta - sitagliptin
agnis 50 mg tablete
belupo, lijekovi i kozmetika, d.d. - vildagliptin - tableta - vildagliptin 50 mg / 1 tableta - vildagliptin
glypvilo 50 mg tablete
vildagliptin - tableta - vildagliptin 50 mg / 1 tableta - vildagliptin
glypvilo 50 mg tablete
vildagliptin - tableta - vildagliptin 50 mg / 1 tableta - vildagliptin
betaserc 24 mg tablete
mylan healtcare gmbh - betahistin - tableta - betahistin 15,6 mg / 1 tableta - betahistin
adimuplan 100 mg filmsko obložene tablete
sitagliptin - filmsko obložena tableta - sitagliptin 100 mg / 1 tableta - sitagliptin
adimuplan 50 mg filmsko obložene tablete
sitagliptin - filmsko obložena tableta - sitagliptin 50 mg / 1 tableta - sitagliptin
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).